University of California San Francisco Give to UCSF

Tau Heterogeneity in Patients on the Alzheimer’s Disease Pathway

Susan M. Landau, PhD
Research Neuroscientist
Helen Wills Neuroscience Institute, University of California, Berkeley
Molecular Biophysics and Integrated Bioimaging, Lawrence Berkeley National Laboratory

Objectives

  • Define the roles of amyloid and tau in Alzheimer's-related cognitive symptoms
  • Understand the phenotypic characteristics of AD patients with elevated and normal tau burden
  • Describe the roles of cardiovascular risk factors and AD pathology in cognitive decline

Disclosures

  • Planners: Bruce L. Miller, MD; Howard J. Rosen, MD; Niyatee Samudra, MD; Ehud Zeltzer, MD; and Eleanor O’Brien have stated they have no relationships to disclose.
  • Speakers: Susan Landau, PhD, has disclosed the following relationships: Eisai Inc and Keife Rx.

Accreditation: The University of California, San Francisco (UCSF) School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation: UCSF designates this live activity for a maximum of 22 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Credit is inclusive of all Memory and Aging Center Grand Rounds sessions offered from January 1, 2022, through December 30, 2022. (1 credit per each 1-hour grand rounds session throughout the year).

Questions? Email Ehud Zeltzer at Ehud.Zeltzer@ucsf.edu or Niyatee Samudra at Niyatee.Samudra@ucsf.edu.

Attendees must register for this event. Grand Rounds presentations are for educational purposes and intended for a professional audience with a terminal degree. This activity is not commercially supported.

Event Details

  • Chenyang Jiang
  • Maria Cogburn

2 people are interested in this event